Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CUPR

Cuprina Holdings (Cayman) Ltd

May 29 • 11:44AM ET

2.27

-1.03 -31.21 %

Healthcare • Medical Instruments & Supplies • Singapore • Nano • NASD

Today, 8:30 AMCuprina announces $9M registered direct offering priced at $1.75, sparking 24% premarket drop

Peers: GCTK LUCY NXGL BNGO RGNT ZJYL FEMY RVP HBIO MLSS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.17	Insider Own	65.66%	Shs Outstand	7.37M	Perf Week	1.70%
Market Cap	2.09M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.37M	Perf Month	5.76%
Enterprise Value	0.05M	PEG	-	EPS next Q	-	Inst Own	0.05%	Short Float	0.47%	Perf Quarter	-22.54%
Income	-3.58M	P/S	52.28	EPS this Y	-	Inst Trans	18.38%	Short Ratio	0.11	Perf Half Y	-57.45%
Sales	0.04M	P/B	12.39	EPS next Y	-	ROA	-90.82%	Short Interest	0.03M	Perf YTD	-29.08%
Book/sh	0.18	P/C	0.86	EPS next 5Y	-	ROE	-1082.72%	52W High	76.00 -97.01%	Perf Year	-94.03%
Cash/sh	2.63	P/FCF	-	EPS past 3/5Y	-65.95% -74.96%	ROIC	-85.52%	52W Low	1.76 28.98%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-2.38% -3.22%	Gross Margin	-54.48%	Volatility	25.76% 16.25%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.28	EPS Y/Y TTM	-208.87%	Oper. Margin	-9692.62%	ATR (14)	0.44	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.35	Sales Y/Y TTM	6.30%	Profit Margin	-9376.19%	RSI (14)	48.92	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	2.35	EPS Q/Q	-223.92%	SMA20	3.39%	Beta	2.94	Target Price	-
Payout	-	Debt/Eq	0.10	Sales Q/Q	277.69%	SMA50	-9.69%	Rel Volume	1.32	Prev Close	3.30
Employees	10	LT Debt/Eq	0.07	Earnings	-	SMA200	-59.38%	Avg Volume	324.34K	Price	2.27
IPO	Apr 10, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	160,997	Change	-31.21%

May-22-26 10:50AM	Cuprina Holdings announces 1-for-8 Share Consolidation (GlobeNewswire)
Mar-11-26 08:30AM	Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board (GlobeNewswire) +8.11%
Dec-09-25 08:30AM	Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth (GlobeNewswire) -6.62%
Dec-05-25 03:14PM	Nasdaq Lists Some Tiny IPOs That Go Up in Flames. Regulators Are Cracking Down. (Barrons.com)
Nov-28-25 08:30AM	Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency (GlobeNewswire)
08:30AM	Loading…
Nov-18-25 08:30AM	Cuprina forms Joint Venture Company with Aiodine Laboratory to Develop and Market Novel Iodine-based Solution as New Wound Care Therapy (GlobeNewswire)
Oct-27-25 08:40AM	Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies (GlobeNewswire) +19.07%
Oct-06-25 08:30AM	Cuprina to Present Live, Answer Questions, at Skyline Signature Series on October 8th, 2025, at 11:00 AM ET (GlobeNewswire)
Sep-09-25 08:05AM	Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology (GlobeNewswire) +12.23%
Aug-18-25 08:00AM	Cuprina Reaffirms Commitment to Shareholders and Patients Following Recent Stock Market Activity (GlobeNewswire) +9.24%
Jul-21-25 09:00AM	Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market (GlobeNewswire) +5.02%
Jun-30-25 08:00AM	Cuprina Provides Update on Research Studies with Three Leading Education Institutes (GlobeNewswire)
Jun-04-25 08:00AM	Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries (GlobeNewswire)
May-08-25 01:05PM	Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering (GlobeNewswire) -7.17%
May-06-25 10:45AM	Cuprina Holdings obtains dealer license for IVF media production facility (TipRanks) +5.38%
12:29PM	Loading…
May-05-25 12:29PM	Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd. (GlobeNewswire) -9.87%
12:27PM	Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering (GlobeNewswire)
12:24PM	Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering (GlobeNewswire)
Apr-12-25 01:30AM	U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility (Seeking Alpha)
Apr-11-25 11:07AM	Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering (GlobeNewswire) +7.95%
Apr-10-25 08:35AM	Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering (GlobeNewswire)

Cuprina Holdings (Cayman) Ltd. engages in the manufacturing, sale, and supply of medical devices to manage and accelerate healing and closure of chronic wounds. Its products include nature-based bioactive, in the form of advanced wound dressings, derived from sustainable sources. The company was founded by Carl Marc Baptista on August 28, 2019 and is headquartered in Singapore.

CEO & DirectorMr. Yong Qi Quek

Chief Financial OfficerMr. Tat Jing Chan

Medical & Scientific DirectorDr. Ronald Sherman

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CUPR

Cuprina Holdings (Cayman) Ltd

Upgrade your Finviz experience